BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25176562)

  • 1. Frontal hypometabolism in elderly breast cancer survivors determined by [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study.
    Ponto LL; Menda Y; Magnotta VA; Yamada TH; Denburg NL; Schultz SK
    Int J Geriatr Psychiatry; 2015 Jun; 30(6):587-94. PubMed ID: 25176562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive deficits and regional brain metabolism in Alzheimer's disease.
    Woo BK; Harwood DG; Melrose RJ; Mandelkern MA; Campa OM; Walston A; Sultzer DL
    Int J Geriatr Psychiatry; 2010 Nov; 25(11):1150-8. PubMed ID: 20069587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between neuropsychological functioning and FDG-PET hypometabolism in intractable mesial temporal lobe epilepsy.
    Knopman AA; Wong CH; Stevenson RJ; Homewood J; Mohamed A; Somerville E; Eberl S; Wen L; Fulham M; Bleasel AF
    Epilepsy Behav; 2015 Mar; 44():136-42. PubMed ID: 25703620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose hypometabolism is highly localized, but lower cortical thickness and brain atrophy are widespread in cognitively normal older adults.
    Nugent S; Castellano CA; Goffaux P; Whittingstall K; Lepage M; Paquet N; Bocti C; Fulop T; Cunnane SC
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1315-21. PubMed ID: 24735889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
    Yoshida K; Ogasawara K; Saura H; Saito H; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Ogawa A
    J Neurosurg; 2015 Dec; 123(6):1546-54. PubMed ID: 26230467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration patterns of brain glucose metabolism: comparisons of healthy controls, subjective memory impairment and mild cognitive impairment.
    Song IU; Choi EK; Oh JK; Chung YA; Chung SW
    Acta Radiol; 2016 Jan; 57(1):90-7. PubMed ID: 25538106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.
    Koppel J; Sunday S; Goldberg TE; Davies P; Christen E; Greenwald BS;
    Am J Geriatr Psychiatry; 2014 Jul; 22(7):698-707. PubMed ID: 23672944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy.
    Silverman DH; Dy CJ; Castellon SA; Lai J; Pio BS; Abraham L; Waddell K; Petersen L; Phelps ME; Ganz PA
    Breast Cancer Res Treat; 2007 Jul; 103(3):303-11. PubMed ID: 17009108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.
    Rabinovici GD; Furst AJ; Alkalay A; Racine CA; O'Neil JP; Janabi M; Baker SL; Agarwal N; Bonasera SJ; Mormino EC; Weiner MW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ
    Brain; 2010 Feb; 133(Pt 2):512-28. PubMed ID: 20080878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional brain glucose metabolism and neurocognitive function in adult survivors of childhood cancer treated with cranial radiation.
    Krull KR; Minoshima S; Edelmann M; Morris B; Sabin ND; Brinkman TM; Armstrong GT; Robison LL; Hudson MM; Shulkin B
    J Nucl Med; 2014 Nov; 55(11):1805-10. PubMed ID: 25315244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic correlates of Rey auditory verbal learning test in elderly subjects with memory complaints.
    Brugnolo A; Morbelli S; Arnaldi D; De Carli F; Accardo J; Bossert I; Dessi B; Famà F; Ferrara M; Girtler N; Picco A; Rodriguez G; Sambuceti G; Nobili F
    J Alzheimers Dis; 2014; 39(1):103-13. PubMed ID: 24150105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
    Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?
    Ossenkoppele R; Madison C; Oh H; Wirth M; van Berckel BN; Jagust WJ
    Cereb Cortex; 2014 Aug; 24(8):2210-8. PubMed ID: 23537530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve.
    Yoshizawa H; Gazes Y; Stern Y; Miyata Y; Uchiyama S
    Psychiatry Res; 2014 Jan; 221(1):78-85. PubMed ID: 24262800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.